NCAA: Nayve makes graceful exit as Benilde outlasts LPU | ABS-CBN

ADVERTISEMENT

dpo-dps-seal
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!

Sports

NCAA: Nayve makes graceful exit as Benilde outlasts LPU

NCAA: Nayve makes graceful exit as Benilde outlasts LPU

Rom Anzures,

ABS-CBN News

Clipboard

CSB’s Robi Nayve. File photo by Mark Demayo, ABS-CBN News
CSB’s Robi Nayve. File photo by Mark Demayo, ABS-CBN News

MANILA — College of Saint Benilde outlasted Lyceum of the Philippines to win the NCAA Men’s Basketball Tournament’s first-ever Battle for Third.

Graduating guard Robi Nayve put up 18 points, five rebounds, and four assists as the Blazers defeated the Pirates, 93-83, Sunday morning at the Mall of Asia Arena in Pasay City.

Joshua Cajucom also starred after putting up 15 markers and six boards, while Miggy Corteza had 15.

After a close encounter in the first 20 minutes of action, the Intramuros-based squad opened the second half on a seven-to-nothing spurt to create a 50-41 with still 8:08 in the third frame.

ADVERTISEMENT

It even grew to as huge as 15, 81-66, in the final quarter following a John Morales and-one at the 6:03 mark.

A free throw by Shawn Umali cut the lead of the Charles Tiu-mentored squad to nine, 78-89, but that was the nearest that they could get as the Taft-based squad went on to bring home the league’s bronze medal.

McLaude Guadaña’s 16 points led the Pirates’ offensive, while Alvin Penafiel got 16.

Korea-bound Mics Oczon and NLEX Road Warriors’ incoming rookie Enoch Valdez did not play.

The Scores:

CSB — 93 - Nayve 18, Cajucom 15, Corteza 14, Marasigan 8, Carlos 7, Gozum 7, Sangco 6, Marcos 5, Morales 4, Lepalam 4, Arciaga 2, Jarque 2, Turco 1, Mara 0, Jalalon 0

LPU — 83 - Guadana 16, Penafiel 15, Montano 9, Umali 8, Barba 8, Cunanan 7, Culanay 6, Versoza 5, Aviles 4, Moralejo 3, Saure 2, Villegas 0

Quarterscores: 24-22; 43-41; 71-56; 93-83

ADVERTISEMENT

ADVERTISEMENT

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.